Memento Medicines News and Activities

Acquisition, funding and merger involving Memento Medicines.

• Memento Medicines has just announced a $93 Million fundraising (posted on June 22 2026).

View the org chart displaying its 1 main executives

Most searched biographies at Memento Medicines

• Naveen Daryani, Chief Executive Officer

Create your alert
to follow the executive moves at Memento Medicines.

Memento Medicines has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Memento Medicines has just announced a $93 Million fundraising (posted on June 22 2026).
• Alvotech has just announced a $165 Million fundraising (posted on June 19 2026).
• Obsidian Therapeutics has filed its IPO. Its stock ticker will be OBX. (posted on June 18 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Memento Medicines

Social media about Memento Medicines

• Memento Medicines on Wikipedia, Google News & Yahoo Finance
• Memento Medicines on LinkedIn, X (Twitter) & YouTube